Posts on Twitter:

Aldeyra's eye drug fails pivotal test in patients with rare, inflammatory disease

NEW: With 200+ Cell & Gene IND Requests Heading to FDA by 2020, Challenges Lie Ahead on Path to Approval:

Did you know graduates of 's Biotechnology Laboratory Sciences Program are employable immediately upon graduation? Become a part of the growing industry by enrolling today! →

Please post your vote for the 2019 trader mascot ... here is mine >>

Excited to be honored by as a "Top 100 Healthcare Leader" advancing innovation in . Working hard to create real value for and innovators and manufacturers

China biotechnology innovation rank - Measuring global biotechnology via Want our free weekly newsletter? Respond and we'll sign you up...

Join and this Thursday for The Future of NYC Life Sciences, gathering the area's leading companies. MSIP's Lisa Placanica will be joining a panel on the new wave of and tech transfer!

🔵 🔵 C'est jolie et précis ce que nous a fait aujourd'hui. Elle rebouche son gap du 13 juin et rebondie illico dans la dernière heure. Le support et la m200 horaire à 4.925 reste préservés, sur le fil quand même.

Retweet Retweeted Like Liked
Replying to and

Omg Some folks r knocking on another door cReating risk 4 everyone like is a game & who is to blame 4 Not using this to activate & Compatible devices instead of

This media may contain sensitive material. Learn more View

5 More Sponsors, 3 More Speakers and 2 More Startups added to Med Tech Monday on July 29th, 2019 - Don't miss early bird pricing for the & Conference! Register your team today! New Larger Venue!

Great deep dive into the anti-FcRn landscape by Piper FcRN is one of the most promising targets in therapeutic development currently, as it has implications in ~40 IgG-mediated autoimmune diseases Players: , Immunovant / Hanall, Affibody & Harbour

Share your research in the poster sessions at the Antibody Pipeline Congress. Present your poster to our international delegation, representing leaders from top , , academic and government institutions. Reserve your spot

When New England Biolabs faced challenges for their new manufacturing facility, they leaned on KTS for alternative options that would solve these challenges:

Posts on Tumblr: